These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 22157621)

  • 1. Clinical stratification of glioblastoma based on alterations in retinoblastoma tumor suppressor protein (RB1) and association with the proneural subtype.
    Goldhoff P; Clarke J; Smirnov I; Berger MS; Prados MD; James CD; Perry A; Phillips JJ
    J Neuropathol Exp Neurol; 2012 Jan; 71(1):83-9. PubMed ID: 22157621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alterations in the RB Pathway With Inactivation of RB1 Characterize Glioblastomas With a Primitive Neuronal Component.
    Chkheidze R; Raisanen J; Gagan J; Richardson TE; Pinho MC; Raj K; Achilleos M; Slepicka C; White CL; Evers BM; Patel TR; Malter JS; Hatanpaa KJ
    J Neuropathol Exp Neurol; 2021 Dec; 80(12):1092-1098. PubMed ID: 34850045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IDH-wild type glioblastomas featuring at least 30% giant cells are characterized by frequent RB1 and NF1 alterations and hypermutation.
    Barresi V; Simbolo M; Mafficini A; Martini M; Calicchia M; Piredda ML; Ciaparrone C; Bonizzato G; Ammendola S; Caffo M; Pinna G; Sala F; Lawlor RT; Ghimenton C; Scarpa A
    Acta Neuropathol Commun; 2021 Dec; 9(1):200. PubMed ID: 34952640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. pRB immunostaining in the differential diagnosis between pleomorphic xanthoastrocytoma and glioblastoma with giant cells.
    Barresi V; Simbolo M; Ciaparrone C; Pedron S; Mafficini A; Scarpa A
    Histopathology; 2022 Nov; 81(5):661-669. PubMed ID: 35945679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CDKN2/p16 or RB alterations occur in the majority of glioblastomas and are inversely correlated.
    Ueki K; Ono Y; Henson JW; Efird JT; von Deimling A; Louis DN
    Cancer Res; 1996 Jan; 56(1):150-3. PubMed ID: 8548755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RB1 gene mutations in Argentine retinoblastoma patients. Implications for genetic counseling.
    Parma D; Ferrer M; Luce L; Giliberto F; Szijan I
    PLoS One; 2017; 12(12):e0189736. PubMed ID: 29261756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sensitive multistep clinical molecular screening of 180 unrelated individuals with retinoblastoma detects 36 novel mutations in the RB1 gene.
    Nichols KE; Houseknecht MD; Godmilow L; Bunin G; Shields C; Meadows A; Ganguly A
    Hum Mutat; 2005 Jun; 25(6):566-74. PubMed ID: 15884040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spectrum of RB1 mutations in argentine patients: 20-years experience in the molecular diagnosis of retinoblastoma.
    Ottaviani D; Parma D; Giliberto F; Ferrer M; Fandino A; Davila MT; Chantada G; Szijan I
    Ophthalmic Genet; 2013 Dec; 34(4):189-98. PubMed ID: 23301675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytoplasmic cyclin D1 regulates glioblastoma dissemination.
    Cemeli T; Guasch-Vallés M; Nàger M; Felip I; Cambray S; Santacana M; Gatius S; Pedraza N; Dolcet X; Ferrezuelo F; Schuhmacher AJ; Herreros J; Garí E
    J Pathol; 2019 Aug; 248(4):501-513. PubMed ID: 30957234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular classification of a complex structural rearrangement of the RB1 locus in an infant with sporadic, isolated, intracranial, sellar region retinoblastoma.
    Schieffer KM; Feldman AZ; Kautto EA; McGrath S; Miller AR; Hernandez-Gonzalez ME; LaHaye S; Miller KE; Koboldt DC; Brennan P; Kelly B; Wetzel A; Agarwal V; Shatara M; Conley S; Rodriguez DP; Abu-Arja R; Shaikhkhalil A; Snuderl M; Orr BA; Finlay JL; Osorio DS; Drapeau AI; Leonard JR; Pierson CR; White P; Magrini V; Mardis ER; Wilson RK; Cottrell CE; Boué DR
    Acta Neuropathol Commun; 2021 Apr; 9(1):61. PubMed ID: 33827698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dysplastic Lipoma: A Distinctive Atypical Lipomatous Neoplasm With Anisocytosis, Focal Nuclear Atypia, p53 Overexpression, and a Lack of MDM2 Gene Amplification by FISH; A Report of 66 Cases Demonstrating Occasional Multifocality and a Rare Association With Retinoblastoma.
    Michal M; Agaimy A; Contreras AL; Svajdler M; Kazakov DV; Steiner P; Grossmann P; Martinek P; Hadravsky L; Michalova K; Svajdler P; Szep Z; Michal M; Fetsch JF
    Am J Surg Pathol; 2018 Nov; 42(11):1530-1540. PubMed ID: 30001242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unilateral retinoblastoma, lack of familial history and older age does not exclude germline RB1 gene mutation.
    Brichard B; Heusterspreute M; De Potter P; Chantrain C; Vermylen C; Sibille C; Gala JL
    Eur J Cancer; 2006 Jan; 42(1):65-72. PubMed ID: 16343894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutational analysis of the RB1 gene in Moroccan patients with retinoblastoma.
    Abidi O; Knari S; Sefri H; Charif M; Senechal A; Hamel C; Rouba H; Zaghloul K; El Kettani A; Lenaers G; Barakat A
    Mol Vis; 2011; 17():3541-7. PubMed ID: 22219649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Co-deleting Pten with Rb in retinal progenitor cells in mice results in fully penetrant bilateral retinoblastomas.
    Xie C; Lu H; Nomura A; Hanse EA; Forster CL; Parker JB; Linden MA; Karasch C; Hallstrom TC
    Mol Cancer; 2015 Apr; 14():93. PubMed ID: 25907958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RB1 germ-line deletions in Argentine retinoblastoma patients.
    Fernández C; Repetto K; Dalamon V; Bergonzi F; Ferreiro V; Szijan I
    Mol Diagn Ther; 2007; 11(1):55-61. PubMed ID: 17286450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The survival gene MED4 explains low penetrance retinoblastoma in patients with large RB1 deletion.
    Dehainault C; Garancher A; Castéra L; Cassoux N; Aerts I; Doz F; Desjardins L; Lumbroso L; Montes de Oca R; Almouzni G; Stoppa-Lyonnet D; Pouponnot C; Gauthier-Villars M; Houdayer C
    Hum Mol Genet; 2014 Oct; 23(19):5243-50. PubMed ID: 24858910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A glycolysis-based ten-gene signature correlates with the clinical outcome, molecular subtype and IDH1 mutation in glioblastoma.
    Chen C; Shi Y; Li Y; He ZC; Zhou K; Zhang XN; Yang KD; Wu JR; Kung HF; Ping YF; Bian XW
    J Genet Genomics; 2017 Nov; 44(11):519-530. PubMed ID: 29169920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Using RB1 mutations to assess minimal residual disease in metastatic retinoblastoma.
    Dimaras H; Rushlow D; Halliday W; Doyle JJ; Babyn P; Abella EM; Williams J; Héon E; Gallie BL; Chan HS
    Transl Res; 2010 Aug; 156(2):91-7. PubMed ID: 20627193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation of heterozygous and homozygous hESC H9 sublines carrying inactivating mutations in RB1.
    Schipper L; Kanber D; Steenpass L
    Stem Cell Res; 2018 Dec; 33():41-45. PubMed ID: 30312872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Uncommon RB1 somatic mutations in a unilateral retinoblastoma patient.
    Ottaviani D; Alonso C; Szijan I
    Medicina (B Aires); 2015; 75(3):137-41. PubMed ID: 26117602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.